Search

everythinglearnresearchcommunity

for

Search:↓

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Testosterone may influence COVID-19 severity and outcomes.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Matriptase is highly active in hair follicles and sebaceous glands, especially during hair growth phases.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.

Organoid technology is advancing and entering commercial use, with applications in disease modeling, drug development, and personalized medicine.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

About 61% of women who had COVID-19 experienced hair loss afterward.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

New understanding and treatments for hair loss are improving, but more research is needed.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

COVID-19 can cause skin symptoms that might help spot the virus early, and treatments for it can also affect the skin.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Correcting nutrient deficiencies may help with hair loss, but the benefits of supplements without a deficiency are uncertain and could be harmful.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Cysteine helps maintain keratin production in skin cells even when iron is low.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Researchers found genes that may explain why some pigs grow winter hair, which could help breed cold-resistant pigs.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.